PDM Drug Chart Brochure 0315 Web

Prescription Drug Monitoring Proﬁles

906253 906258 706263 906249 906254 906259 906507 906508 Base Pro le Profile 1 Profile 1 Profile 1 w/Con rmation w/Con rmation Base Profile Base Profile w/Con rmation Profile 1 Profile 1 w/D/L Isomers w/ Con rmation w/medMATCHTM w/Con rmation w/o Con rmation w/medMATCHTM w/Con rmation w/o Con rmation w/medMATCHTM w/ D/L Isomers Amphetamines • • • • • Barbiturates • • • • • Benzodiazepines • • • • • • • • Cocaine • • • • • • • • Marijuana • • • • • Methadone • • • • • Opiates • • • • • • • • Oxycodone • • • • • • • • Phencyclidine • • • • • Individual components are orderable separately. Please refer to our Prescription Drug Monitoring laboratory request form or the Prescription Drug Monitoring section of our Reference Manual.

For assistance with interpreting Prescription Drug Monitoring Results, please contact a Toxicology Specialist at 1-877-40-RX TOX (1-877-407-9869), M–F 8am to 6pm EST.

SonoraQuest.com Sonora Quest Laboratories, any associated logos, and all associated Sonora Quest Laboratories registered or unregistered trademarks are the property of Sonora Quest Laboratories. All third party marks - ® and ™ - are the property of their respective owners. © 2015 Sonora Quest Laboratories. All rights reserved. 3/2015 QuestDiagnostics.com Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third party marks - ® and ™ - are the property of their respective owners. © 2015 Quest Diagnostics. All rights reserved. 3/2015

® #1 Bioscience Firm 2015 0315

Prescription Drug Monitoring Reference Guide

Alcohol Metabolites LC-MS/MS 500 1-3 Days Ethyl Sulfate (EtS) Ethyl 100 Glucuronide (EtG) Amphetamine None Amphetamine Adderall®, Dexedrine®, Dextrostat®, 250 Amphetamines EIA 500 Vyvanse® 1-3 Days Methamphetamine Amphetamine Methamphetamine Desoxyn® 250 Amphetamine None Amphetamine Adderall®, Dexedrine®, Dextrostat®, 250 Vyvanse® Amphetamines with Methamphetamine d/l EIA 500 Methamphetamine Amphetamine Methamphetamine Desoxyn® 250 1-3 Days Isomers d-Methamphetamine None d-Methamphetamine Desoxyn® 250 l-Methamphetamine None l-Methamphetamine Vicks Inhaler®, Selegiline® 250 Amobarbital (Secobarbital Amobarbital Amytal® 100 Combination) Tuinal® - (Amobarbital/ Secobarbital Combination) Butalbital None Butalbital Esgic®, Fioricet®, Fiorinal®, Sandoptal® 100 1-3 Days Short Barbiturates EIA 300 Acting; >3 Long Pentobarbital None Pentobarbital Nembutal® 100 Acting Secobarbital (Amobarbital Secobarbital Seconal®, Tuinal® - (Amobarbital/ 100 Combination) Secobarbital Combination) Phenobarbital None Phenobarbital Luminal® 100

For assistance with interpreting Prescription Drug Monitoring Results, please contact a Toxicology Specialist at 1-877-40-RX TOX (1-877-407-9869), M–F 8am to 6pm EST. Source of Drug Metabolite Mass Initial Additiona l Screen Spectrometry Urine Screen Drug Quantitations/ Metabolites / Common Trade / Drug/Drug Class Method of Generic Name Quantitative/ Detection Cuto Conﬁrmations Compound s Street Name Analysis Conﬁrmation Time (ng/mL) Often Present

Alphahydroxyalprazolam None Alprazolam Xanax® 25 Alphahydroxymidazolam None Midazolam Versed® 50 Alphahydroxytriazolam None Triazolam Halcion® 50 Aminoclonazepam None Clonazepam Klonopin® 25 Hydroxyethylﬂurazepam None Flurazepam Dalmane® 50 Lorazepam None Lorazepam Ativan® 50 1-3 Days Short Nordiazepam Oxazepam, Chlordiazepoxide, Chlordiazepoxide - Librium®, 50 Benzodiazepines EIA 100 Acting; >3 Long Temazepam Clorazepate, Clorazepate - Tranxene®, Acting Diazepam Diazepam - Valium® Oxazepam Nordiazepam, Temazepam Chlordiazepoxide, Chlordiazepoxide - Librium®, 50 Clorazepate, Diazepam, Clorazepate - Tranxene®, Oxazepam, Temazepam Diazepam - Valium®, Oxazepam - Librax®, Serax®, Temazepam - Restoril® Temazepam Oxazepam, Nordiazepam Diazepam, Temazepam Restoril®, Valium® 50 Buprenorphine Norbuprenorphine 2 Buprenorphine EIA 5 Buprenorphine Suboxone®, Subutex® 1-3 Days Norbuprenorphine None 2 Carisoprodol Meprobamate None Carisoprodol Soma®, Equagesic® 1000 1-3 Days Cocaine Metabolite EIA 150 Benzoylecgonine None Cocaine Coke 100 1-3 Days Fentanyl Norfentanyl Abstral®, Actiq®, Duragesic®, 0.5 Fentanyl Fentanyl 1-2 Days Norfentanyl None Fentora®, Ionsys® 0.5 Gabapentin Gabapentin None Gabapentin Fanatrex, Gabarone, Neurontin 1000 1-3 Days Heroin Metabolite EIA 10 6-Acetylmorphine None Heroin Heroin 10 1 Day Marijuana Metabolite EIA 20 Marijuana Metabolite None Marijuana Marinol®, Dronabinol® 5 1-3 Days Casual Use; >3 Chronic Use MDA None MDA Ecstasy, Sally 200 MDMA/MDA EIA 500 1-2 Days MDMA MDA MDMA Ecstasy 200 Meperidine Normeperidine 100 Meperidine Meperidine Demerol® 1-3 Days Normeperidine None 100 Methadone EDDP 100 Methadone Metabolite EIA 100 Methadone Dolophine® 1-3 Days EDDP None 100

Source of Drug Metabolite Mass Initial Additional Screen Spectrometry Urine Screen Drug Quantitations/ Metabolites / Common Trade / Drug/Drug Class Method of Generic Name Quantitative/ Detection Cuto Conﬁrmations Compounds Street Name Analysis Time (ng/mL) Often Present Conﬁrmation Cuto (ng/mL) d-Methamphetamine None d-Methamphetamine Desoxyn® 250 Methamphetamine d/l Isomers 1-3 Days l-Methamphetamine None l-Methamphetamine Vicks Inhaler®, Selegiline® 250 Methylphenidate Ritalinic Acid None Methylphenidate Ritalin®, Concerta® 100 1-3 Days Codeine Morphine Codeine Tylenol #3®, Tylenol #4®, Tylenol w/ 50 (Hydrocodone - Codeine®, Acetaminophen w/ Codeine®, Minor Metabolite) Phenaphen w/ Codeine®, Phenergan w/ Codeine®, Phenameth w/ Codeine®, Promethazine w/ Codeine® Morphine (Hydromorphone - Morphine Avinza®, Kadian®, 50 Opiates EIA 100 Minor Metabolite) MS Contin®, Roxanol® 1-3 Days Hydrocodone Hydromorphone, Hydrocodone Hycodan®, Lorcet®, Lortab®, Norco®, 50 Norhydrocodone Vicodin® Hydromorphone None Hydromorphone Dilaudid® 50 Norhydrocodone Hydromorphone Hydrocodone Hycodan®, Lorcet®, Lortab®, Norco®, 50 Vicodin®

Noroxycodone Oxycodone, Endocet®, Magnacet®, OxyContin®, 50 Oxymorphone OxyFAST®, OxyIR®, Percocet®, Oxycodone Oxycodone EIA 100 Oxycodone Noroxycodone, Percodan®, Perolox®, Roxicet®, 50 1-3 Days Oxymorphone Roxicodone®, Tylox® Oxymorphone None Oxymorphone Opana®, Numorphan® 50 Phencyclidine EIA 25 Phencyclidine None Phencyclidine PCP 25 1-3 Days Pregabalin Pregabalin None Pregabalin Lyrica® 1000 1-3 Days Tapentadol Nortapentadol 50 Tapentadol Tapentadol Nucynta® 1-3 Days Nortapentadol None 50 Tramadol Desmethyltramadol 100 Tramadol Tramadol Rybix®, Ryzolt®, Ultram® 1-3 Days Desmethyltramadol None 100 Amitriptyline Nortriptyline Amitriptyline, Elavil® 100 Tricyclic Antidepressants Nortriptyline 1-3 Days Nortriptyline None Nortriptyline Aventyl®, Pamelor® 100 Source of Drug Metabolite Mass Initial Additiona l Screen Spectrometry Urine Screen Drug Quantitations/ Metabolites / Common Trade / Drug/Drug Class Method of Generic Name Quantitative/ Detection Cuto Conﬁrmations Compound s Street Name Analysis Conﬁrmation Time (ng/mL) Often Present

For assistance with interpreting Prescription Drug Monitoring Results, please contact a Toxicology Specialist at 1-877-40-RX TOX (1-877-407-9869), M–F 8am to 6pm EST.

® #1 Bioscience Firm 2015 0315

Prescription Drug Monitoring Reference Guide

For assistance with interpreting Prescription Drug Monitoring Results, please contact a Toxicology Specialist at 1-877-40-RX TOX (1-877-407-9869), M–F 8am to 6pm EST.